Skip to main content
. 2022 Aug 2;15:983–1003. doi: 10.2147/JAA.S374346

Box 3.

Practical Considerations for the Use of Systemic Corticosteroids

  • Not indicated as a standard treatment of AR.

  • Risks outweigh benefits.

  • Can be used in the secondary-care setting for severe and therapy-resistant symptoms, especially for AR with comorbid bronchial asthma or nasal polyposis.

  • When required, only short course of systemic corticosteroids (not exceeding 5 days) should be given.

  • Refrain from use in the primary-care setting due to safety concerns.

Abbreviation: AR, allergic rhinitis.